Status:

COMPLETED

An Exploratory Study of Tramadol Hydrochloride in Patients With Osteoarthritis of the Knee or Low Back Pain

Lead Sponsor:

Janssen Pharmaceutical K.K.

Conditions:

Osteoarthritis

Low Back Pain

Eligibility:

All Genders

20-74 years

Phase:

PHASE2

Brief Summary

The purpose of this study is to find the clinical dose range of an active ingredient of JNS013 - Tramadol hydrochloride in chronic-pain patients who cannot attain a sufficient analgesic effect from no...

Detailed Description

Since JNS013 is a combination of tramadol hydrochloride (TRAM) acting as a weak opioid with acetaminophen (APAP) inhibiting central COX-3, it is expected to have an intermediate effect between narcoti...

Eligibility Criteria

Inclusion

  • Patients with chronic pain due to OA of the knee or LBP that persists for more than 3 months at the initiation of the observation period
  • Patients who received oral NSAIDs at a usual highest dose for at least 14 consecutive days during 3 months before the initiation of the observation period, but could not attain a sufficient analgesic effect
  • Patients with the intensity of the strongest pain during 48 hours before the initiation of the observation period is \>= 40 mm and \< 80 mm on VAS
  • Ambulatory outpatients
  • Prior to the conduct of the study, patients who were given a sufficient explanation about the investigational product and this study and have given their own consent in writing to participate in the study.

Exclusion

  • Patients with conditions for which opioids are contraindicated
  • Patients with a hypersensitivity to opioids
  • Patients who received TRAM in the past and discontinued the treatment due to ineffectiveness or adverse reactions
  • Patients with complications associated with pain to the degree considered to have an influence on the efficacy assessment (trauma such as fracture, headache, post-herpetic neuralgia)
  • Patients with a complication of severe spinal disease

Key Trial Info

Start Date :

June 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2007

Estimated Enrollment :

119 Patients enrolled

Trial Details

Trial ID

NCT00752661

Start Date

June 1 2007

End Date

November 1 2007

Last Update

May 17 2011

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.